Published 2006
| Version v1.0.0
Journal Article
Open
Trial of Immune Globulin in Infant Botulism
- Creators
- Millichap, J. Gordon
Abstract
A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV) in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by type B toxin) was conducted at the California Department of Health Services, Richmond, CA; National Botulism Surveillance and Reference Laboratory, CDC and P, Atlanta; and Division of Biostatistics, University of California, Berkeley.
Files
PNB-20-13.pdf
Files
(1.2 MB)
Name | Size | Download all |
---|---|---|
md5:559d3e7b38e3662ccd2e014873e37bc7
|
1.2 MB | Preview Download |
Additional details
- Other
- PNB-20-13
- Created
-
2006When the item was originally created.